A detailed history of Drive Wealth Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Drive Wealth Management, LLC holds 29,551 shares of HROW stock, worth $1.18 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
29,551
Previous 18,117 63.11%
Holding current value
$1.18 Million
Previous $239,000 158.16%
% of portfolio
0.17%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$10.0 - $21.64 $114,340 - $247,431
11,434 Added 63.11%
29,551 $617,000
Q1 2024

Apr 22, 2024

BUY
$9.3 - $13.23 $168,488 - $239,687
18,117 New
18,117 $239,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.08B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Drive Wealth Management, LLC Portfolio

Follow Drive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drive Wealth Management, LLC with notifications on news.